We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Gene and Cell Therapy – News and Features

News

SR Pharma Announces key Scientific Publications on Therapeutic RNAi

Atugen’s scientists demonstrated systemic delivery of proprietary siRNA molecules for RNAi in vivo and its therapeutic applications in oncology.
News

Researcher Reports Data on Effects of Posiphen™ on Human Neuronal Stem Cells

Posiphen may support stem cell transplantation in Alzheimer's disease.
News

Cytori Demonstrates Adipose Stem and Regenerative Cells Reduce Incidence of Arrhythmia After Heart Attacks

The data suggest adipose stem and regenerative cells are not associated with increased risk of arrhythmias.
News

First SCID Gene Chip to be Introduced at Academy Meeting on Immunodeficiencies

The introduction of this technology will have significant impact, not only on SCID newborns, but a wide variety of diseases and disorders.
News

Invitrogen Taps Renowned Stem Cell Expert Mahendra Rao to Lead new Research Area

Company transforms group of highly-utilized products into Ssem cell platform.
News

Cellular Drug Delivery from the Inside out

Mesoporous nanospheres could deliver drugs to cancer cells while leaving healthy cells unharmed.
News

CytoGenix Receives First Order for synDNA™

Aldevron purchases synDNA™ to offer a broader range of solutions to gene therapy and DNA vaccine researchers.
News

Gene to Screen Track at SCIpharm 2006 Aimed at the Biological Scientist

Now in its second year, the SCIpharm 2006 conference (May 14-17, EICC, Edinburgh, Scotland) will cover all aspects of modern R&D in a four-track format - Gene to Screen, Screen to Candidate, Candidate to Drug and Where Science Meets Business.
News

Introgen Awarded Patent for Gene-Based Therapies Combined with Conventional Therapies

Patent covers any therapeutic gene in combination with radiation and chemotherapy.
News

RheoGene Grants Ichor License to Develop a Regulated Gene Therapy

Ichor has granted an option for RheoGene to license Ichor’s TriGrid™ Delivery System to develop proprietary therapeutics.
Advertisement